News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

NovaBay Pharmaceuticals, Inc. (NBY)’s New Product For Serious Eye Conditions Highlighted In CEOLIVE.TV Interview


7/3/2014 6:09:54 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical company focusing on non-antibiotic anti-infectives, announced today that CEOLIVE.TV, an online service that delivers news about companies to investors, has highlighted NovaBay’s important advance in eye care through an interview with Kathryn Najafi-Tagol, M.D., the founder and director of the Eye Institute of Marin in San Rafael, California.

In the interview with Mike Elliott of CEOLIVE.TV, Dr. Najafi-Tagol described the success she’s been having with NovaBay’s new i-LidTM Cleanser:

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES